11 May 2021: Original Paper
Surgical Outcome of Pulmonary Metastasectomy for Hepatocellular Carcinoma Recurrence in Liver Transplant Patients
Yong Ho Jeong 1ABCDEFG , Shin Hwang 2ACDEF , Geun Dong Lee 1AB , Se Hoon Choi 1AB , Hyeong Ryul Kim 1AB , Yong-Hee Kim 1AB , Seung-Il Park 1AB , Dong Kwan Kim 1ABCDEFG*DOI: 10.12659/AOT.930383
Ann Transplant 2021; 26:e930383
Table 3 Univariate and multivariate analysis of factors associated with patient survival.
| Variable | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| p-Value | HR | 95% CI | p-Value | |
| Recurrence-free period | 0.014 | 0.56 | 0.37–0.89 | 0.008 |
| Number of pulmonary metastasis | 0.43 | |||
| Size of pulmonary metastasis | 0.41 | |||
| Level of AFP at metastasectomy | 0.027 | 2.79 | 1.36–5.72 | 0.005 |
| Postmetastasectomy chemotherapy | 0.003 | 3.68 | 1.49–9.07 | 0.005 |
| AFP – alpha-fetoprotein; HR – hazard ratio; CI – confidence interval. | ||||